Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Israel-based Teva Pharmaceuticals will sell its remaining women's health assets in two deals, totaling $1.38 billion, according to the Philadelphia Business Journal.
The Food and Drug Administration on Tuesday approved Teligent's triamcinolone acetonide cream.
Symbiomix Therapeutics on Monday earned Food and Drug Administration approval for its antibiotic Solosec.
The Food and Drug Administration has approved seven biosimilars drugs since 2015, but only three are on the market, reports Bloomberg.
The National Institutes of Health allocated about $15 million in funding to 13 two-year research initiatives creating 3-D microphysiological system platforms that model human disease.
The California State Board of Pharmacy is pursuing disciplinary action against an off-campus UC Los Angeles pharmacy after an investigation last October revealed the facility compounded drugs with "expired and potentially dangerous ingredients," The Los Angeles Times reports.
Here are six drug companies that made headlines in the past week.
Rural hospitals often struggle to keep expensive rare disease drugs stocked and available for patients, since they must pay full price for the medications through the 340B Drug Discount Program, reports NPR.
Here are the five latest drugs or medical devices approved by the Food and Drug Administration in the past week.
The Food and Drug Administration on Thursday approved Amgen and Allergan's biosimilar version of Roche's cancer drug Avastin.